Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals-Reference-Cited by-同舟云学术

Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals

Published:2021-10-19 Issue:12 Volume:73 Page:2179-2188
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

England Bryant R.¹^ORCID,Roul Punyasha²,Yang Yangyuna²,Kalil Andre C.²,Michaud Kaleb³,Thiele Geoffrey M.¹,Sauer Brian C.⁴^ORCID,Baker Joshua F.⁵^ORCID,Mikuls Ted R.¹^ORCID

Affiliation:

1. VA Nebraska‐Western Iowa Health Care System and University of Nebraska Medical Center Omaha

2. University of Nebraska Medical Center Omaha

3. University of Nebraska Medical Center, Omaha, and FORWARD—The National Databank for Rheumatic Diseases Wichita Kansas

4. VA Salt Lake City Health Care System and University of Utah

5. Corporal Michael J. Crescenz VAMC and University of Pennsylvania Philadelphia

Funder

U.S. Department of Veterans Affairs

Rheumatology Research Foundation

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41800

Reference34 articles.

1. Rheumatoid Arthritis

2. Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

3. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

4. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

5. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system;Intelligent Pharmacy;2024-08

2. COVID-19 in patients with rheumatic diseases: frequency and course;Medical alphabet;2024-07-21

3. In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing;PLOS ONE;2024-07-18

4. Verlauf der COVID-19-Pandemie bei pädiatrisch-rheumatologischen Patienten in Deutschland über die ersten 3 Jahre (2020 bis 2022);Zeitschrift für Rheumatologie;2024-06-06

5. NETosis and SARS-COV-2 Infection-Related Autoimmunity: A Narrative Review;Journal of Advanced Immunopharmacology;2024-05-15